These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28906458)

  • 1. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
    Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.
    Tamada H; Naito H; Kitamori K; Hayashi Y; Yamagishi N; Kato M; Nakajima T
    PLoS One; 2016; 11(1):e0145939. PubMed ID: 26727365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
    Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats.
    Watanabe S; Kumazaki S; Kusunoki K; Inoue T; Maeda Y; Usui S; Shinohata R; Ohtsuki T; Hirohata S; Kusachi S; Kitamori K; Mori M; Yamori Y; Oka H
    J Atheroscler Thromb; 2018 May; 25(5):439-453. PubMed ID: 29162773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    Yetti H; Naito H; Yuan Y; Jia X; Hayashi Y; Tamada H; Kitamori K; Ikeda K; Yamori Y; Nakajima T
    PLoS One; 2018; 13(2):e0192863. PubMed ID: 29438418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
    Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Komeda K; Masubuchi S; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2017 Jul; 134(3):139-146. PubMed ID: 28673635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway.
    Ma Z; Chu L; Liu H; Li J; Zhang Y; Liu W; Dai J; Yi J; Gao Y
    Int Immunopharmacol; 2016 Sep; 38():377-84. PubMed ID: 27351828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat-cholesterol diet mainly induced necrosis in fibrotic steatohepatitis rat by suppressing caspase activity.
    Yetti H; Naito H; Jia X; Shindo M; Taki H; Tamada H; Kitamori K; Hayashi Y; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2013 Nov; 93(18-19):673-80. PubMed ID: 24071521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet.
    Jang SA; Lee S; Sohn EH; Yang J; Park DW; Jeong YJ; Kim I; Kwon JE; Song HS; Cho YM; Meng X; Koo HJ; Kang SC
    Nutr Res; 2016 Sep; 36(9):914-924. PubMed ID: 27632911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
    Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
    Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis.
    Ichimura M; Masuzumi M; Kawase M; Sakaki M; Tamaru S; Nagata Y; Tanaka K; Suruga K; Tsuneyama K; Matsuda S; Omagari K
    J Nutr Biochem; 2017 Feb; 40():62-69. PubMed ID: 27863346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.
    Watanabe S; Kumazaki S; Yamamoto S; Sato I; Kitamori K; Mori M; Yamori Y; Hirohata S
    Int J Exp Pathol; 2018 Dec; 99(6):282-294. PubMed ID: 30680827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.